Intellia Therapeutics: Reinforcing the Promise of Potentially Curing Diseases

Intellia Therapeutics in the News
Intellia Therapeutics (NTLA) presented the first demonstration of physiological protein levels of human alpha-1 antitrypsin (AAT) in non-human primates (NHPs) following a single administration. 
Intellia Therapeutics Liver Gene Insertion Technology
Intellia’s targeted liver gene insertion technology has the ability to achieve therapeutic levels of protein . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.